Search results for CD48

PE/Cyanine7 anti-mouse CD48 Antibody anti-CD48 - HM48-1, BioLegend, 103424

The HM48-1 antibody is useful for blockingin vitroandin vivoCD48 mediated interactions. Additional reported applications (for the relevant formats) include: immunoprecipitation1, costimulation of T cell proliferation1,2, blocking of CD48-CD2 interaction1, and inhibition of CTL activity and graft rejection1,2. Forin vivostudies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. Nos. 103452-103456) with a lower endotoxin limit (Endotoxin < 0.01 EU/µg).

PerCP/Cyanine5.5 anti-mouse CD48 Antibody anti-CD48 - HM48-1, BioLegend, 103421

The HM48-1 antibody is useful for blockingin vitroandin vivoCD48 mediated interactions. Additional reported applications (for the relevant formats) include: immunoprecipitation1, costimulation of T cell proliferation1,2, blocking of CD48-CD2 interaction1, and inhibition of CTL activity and graft rejection1,2. Forin vivostudies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. Nos. 103452-103456) with a lower endotoxin limit (Endotoxin < 0.01 EU/µg).

PerCP/Cyanine5.5 anti-mouse CD48 Antibody anti-CD48 - HM48-1, BioLegend, 103422

The HM48-1 antibody is useful for blockingin vitroandin vivoCD48 mediated interactions. Additional reported applications (for the relevant formats) include: immunoprecipitation1, costimulation of T cell proliferation1,2, blocking of CD48-CD2 interaction1, and inhibition of CTL activity and graft rejection1,2. Forin vivostudies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. Nos. 103452-103456) with a lower endotoxin limit (Endotoxin < 0.01 EU/µg).

TotalSeq™-B0429 anti-mouse CD48 Antibody, CD48, HM48-1, BioLegend, 103457

The HM48-1 antibody is useful for blockingin vitroandin vivoCD48 mediated interactions. Additional reported applications (for the relevant formats) include: immunoprecipitation1, costimulation of T cell proliferation1,2, blocking of CD48-CD2 interaction1, and inhibition of CTL activity and graft rejection1,2. Forin vivostudies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. Nos. 103452-103456) with a lower endotoxin limit (Endotoxin < 0.01 EU/µg).

TotalSeq™-C0429 anti-mouse CD48 Antibody, CD48, HM48-1, BioLegend, 103459

The HM48-1 antibody is useful for blockingin vitroandin vivoCD48 mediated interactions. Additional reported applications (for the relevant formats) include: immunoprecipitation1, costimulation of T cell proliferation1,2, blocking of CD48-CD2 interaction1, and inhibition of CTL activity and graft rejection1,2. Forin vivostudies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. Nos. 103452-103456) with a lower endotoxin limit (Endotoxin < 0.01 EU/µg).

TotalSeq™-A0429 anti-mouse CD48 Antibody, CD48, HM48-1, BioLegend, 103447

The HM48-1 antibody is useful for blockingin vitroandin vivoCD48 mediated interactions. Additional reported applications (for the relevant formats) include: immunoprecipitation1, costimulation of T cell proliferation1,2, blocking of CD48-CD2 interaction1, and inhibition of CTL activity and graft rejection1,2. Forin vivostudies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. Nos. 103452-103456) with a lower endotoxin limit (Endotoxin < 0.01 EU/µg).

CD48 antibody [HM48-1], Genetex, GTX14423

CD48 antibody (MEM-102), Covalab, Ref 00113266

CD48 antibody [OX-78], Genetex, GTX76627

Anti-CD48 antibody [EPR4108], Abcam, AB134049

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .